Medicare Enrolled
Mahmood Kazmi
Optician · Bronx, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Kazmi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Kazmi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Kazmi
Mahmood Kazmi is an optician specialist in Bronx, NY, with 20 years of NPI registration. Based on federal Medicare data, Kazmi performed 5,208 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Kazmi received a total of $183,857 from 66 pharmaceutical and/or device companies across 1375 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Kazmi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 15% volume in NY
$183,857 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗5,208
Medicare services
Top 15% in NY for optician
Not available
Unique patients (not deduplicated)
$104
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Initial nursing facility care, high complexity An initial visit by a healthcare provider to a patient in a nursing facility involving a high level of medical decision making, lasting at least 45 minutes. |
1,335 | $163 | $328 |
| Nursing facility visit, moderate complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes. |
965 | $97 | $247 |
| Psychotherapy and evaluation, 30 minutes A combined session involving psychotherapy and an evaluation and management visit lasting 30 minutes. |
721 | $56 | $248 |
| Nursing facility visit, low complexity A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care. |
420 | $68 | $249 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
364 | $79 | $200 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
275 | $112 | $299 |
| Neurobehavioral status exam, first hour A clinical assessment of neurobehavioral status lasting one hour. This evaluation examines mental and behavioral functions. |
167 | $71 | $250 |
| Initial nursing facility care, moderate complexity Initial care provided to a patient in a nursing facility with moderate medical decision making, taking at least 35 minutes. |
139 | $122 | $259 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
109 | $43 | $200 |
| Health risk assessment administration and interpretation This procedure involves administering a health risk assessment to a patient and interpreting the results. |
104 | $2 | $50 |
| Psychiatric diagnostic evaluation with medical services A psychiatric assessment that includes medical services to evaluate mental health conditions. |
94 | $162 | $473 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
77 | $151 | $348 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
73 | $58 | $200 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
67 | $158 | $350 |
| Nursing facility visit, high complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves a high level of medical decision making and takes at least 45 minutes. |
54 | $137 | $383 |
| Annual depression screening | 52 | $22 | $75 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
37 | $120 | $450 |
| Chronic care management services Comprehensive assessment and care planning for patients requiring ongoing chronic care management. |
37 | $57 | $200 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
31 | $72 | $125 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
28 | $91 | $200 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
23 | $52 | $75 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
21 | $99 | $195 |
| New patient office visit, complex (60-74 min) | 15 | $205 | $350 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$183,857
Total received (2018-2024)
Avg $26,265/year across 7 years
Top 3% in NY for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
66
Companies
1,375
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$13,560
2023
$37,666
2022
$33,637
2021
$48,328
2020
$30,348
2019
$17,363
2018
$2,955
Payments by company (2024)
ABBVIE INC.
$11,648
PFIZER INC.
$460
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$428
Otsuka America Pharmaceutical, Inc.
$399
Novartis Pharmaceuticals Corporation
$146
EMD Serono, Inc.
$101
Alexion Pharmaceuticals, Inc.
$59
Amneal Pharmaceuticals LLC
$40
Neuronetics, Inc.
$35
Eisai Inc.
$32
Neurelis, Inc.
$27
Alkermes, Inc.
$26
Lundbeck LLC
$24
Teva Pharmaceuticals USA, Inc.
$22
Biogen, Inc.
$21
ARGENX US, INC.
$19
Medtronic, Inc.
$17
Amgen Inc.
$16
Sumitomo Pharma America, Inc.
$15
Aucta Pharmaceuticals, Inc.
$13
Lilly USA, LLC
$13
Top 3 companies account for 92.4% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$72,555
Allergan, Inc.
$32,978
AbbVie Inc.
$30,558
Allergan Inc.
$15,384
Biohaven Pharmaceuticals, Inc.
$11,735
Biohaven Pharmaceutical Holding Company Ltd.
$7,128
Amneal Pharmaceuticals LLC
$1,338
Teva Pharmaceuticals USA, Inc.
$1,053
Novartis Pharmaceuticals Corporation
$937
PFIZER INC.
$923
EMD Serono, Inc.
$922
ITI, Inc.
$686
Otsuka America Pharmaceutical, Inc.
$622
Avanir Pharmaceuticals, Inc.
$610
Lundbeck LLC
$577
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$428
NOVARTIS PHARMACEUTICALS CORPORATION
$376
Alexion Pharmaceuticals, Inc.
$367
Adamas Pharmaceuticals, Inc.
$359
Biogen, Inc.
$322
Amgen Inc.
$316
ACADIA Pharmaceuticals Inc
$288
GENZYME CORPORATION
$257
Acorda Therapeutics, Inc
$208
E.R. Squibb & Sons, L.L.C.
$200
Medtronic, Inc.
$188
Janssen Pharmaceuticals, Inc
$188
BOSTON SCIENTIFIC CORPORATION
$173
Medtronic USA, Inc.
$141
Kyowa Kirin, Inc.
$129
Lilly USA, LLC
$128
Shire North American Group Inc
$115
Eisai Inc.
$108
UCB, Inc.
$108
Grifols USA, LLC
$105
Impax Laboratories, Inc.
$103
Abbott Laboratories
$99
Neurocrine Biosciences, Inc.
$88
Axsome Therapeutics, Inc.
$84
Currax Pharmaceuticals LLC
$69
SK Life Science, Inc.
$69
Mallinckrodt Enterprises LLC
$63
CSL Behring
$63
ARGENX US, INC.
$61
Baxter Healthcare
$55
Sumitomo Pharma America, Inc.
$54
Almatica Pharma LLC
$52
Neurelis, Inc.
$46
Takeda Pharmaceuticals U.S.A., Inc.
$45
Celgene Corporation
$36
Neuronetics, Inc.
$35
Horizon Therapeutics plc
$35
Vertical Pharmaceuticals, LLC
$32
GE HealthCare
$30
Mallinckrodt LLC
$27
Alkermes, Inc.
$26
Alnylam Pharmaceuticals Inc.
$25
US WorldMeds, LLC
$22
Genentech USA, Inc.
$21
Merck Sharp & Dohme LLC
$20
MITSUBISHI TANABE PHARMA AMERICA, INC.
$19
Supernus Pharmaceuticals, Inc.
$15
Kowa Pharmaceuticals America, Inc.
$15
Bausch Health US, LLC
$14
Aucta Pharmaceuticals, Inc.
$13
Vanda Pharmaceuticals Inc.
$12
Top 3 companies account for 74.0% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVA · ADASUVE · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APTIOM · AUBAGIO · AUSTEDO · Aimovig · Austedo XR · Auvelity · BELSOMRA · BOTOX · BOTOX THERAPEUTIC · BRINTELLIX · Briviact · CAPLYTA · COMIRNATY · CONTRAVE · DUOPA · EMGALITY · Fycompa · GOCOVRI · GRALISE · Gamunex-C · HETLIOZ · Hillrom - Carnation Ambulatory Monitor · Hizentra · INBRIJA · INFINITY · INGREZZA · INTELLIS ADAPTIVESTIM · Infinity DBS Pulse Generators · KESIMPTA · LEMTRADA · LINZESS · LYBALVI · LYRICA · LYVISPAH · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · MYDAYIS · Mavenclad · Motpoly XR · NAMZARIC · NEUROSTAR TMS THERAPY SYSTEM · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nourianz · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONPATTRO · OSMOLEX ER · PANZYGA · PERCEPT PC BRAINSENSE · QULIPTA · RADICAVA · REXULTI · RYTARY · Rebif · SEGLENTIS · SKYCLARYS · SOLIRIS · SPECTRA WAVEWRITER · SPINRAZA · Soliris · TECFIDERA · TRINTELLIX · TYSABRI · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VIIBRYD · VRAYLAR · VYEPTI · VYVANSE · VYVGART · VYVGART HYTRULO · Vimpat · Xadago · ZEPOSIA · ZOMIG
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Opticians in nearby ZIP areas
16,489
County median income
$49,036
Nearest hospital to ZIP centroid (approximate)
MONTEFIORE MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Kazmi is a clinical cardiology specialist, with above-average Medicare volume (top 15% in NY), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Kazmi experienced with initial nursing facility care, high complexity?
Based on Medicare claims data, Kazmi performed 1,335 initial nursing facility care, high complexity services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Kazmi receive payments from pharmaceutical companies?
Yes. Kazmi received a total of $183,857 from 66 companies across 1,375 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Kazmi's costs compare to other opticians in Bronx?
Kazmi's average Medicare payment per service is $104. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Kazmi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Bronx
Browse opticians in Bronx ranked by procedure volume and transparency data.
Highest volume
Top Opticians in NY
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in NY
Which NY opticians receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Allergan, Inc. Payments to Doctors
See all physicians who received payments from Allergan, Inc.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology